Tag: Prescription Drugs

Improvement seen in all signs of photoaging as early as week 4 and through 12 weeks, with no major irritation

Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic

Oxytocin was required less often before delivery for women receiving vaginal versus oral misoprostol

Etidronate seems to slow progression of further vascular calcification

Lower risk for clinically relevant bleeding seen in acute coronary syndrome, with no increase in risk for MACCE

Lower risks for first heart failure hospitalization, total heart failure hospitalization seen with empagliflozin

Fewer than half of cancer drugs granted accelerated approval demonstrate clinical benefit

Improved overall survival, progression-free survival seen, including among patients with low PD-L1 expression

Findings seen in large study of commercially insured outpatients examining seven biologics, before and after biosimilar availability

Reduction seen in incidence of composite outcome of all-cause mortality, return to hospital with MAUD initiation at discharge